Capstone Therapeutics Corp. (CAPS)

Last Closing Price: 1.12 (2025-10-13)

Company Description

Capstone Holding Corp. primary business activities presently include the operations of TotalStone LLC, a construction materials company. Capstone Holding Corp. is headquartered in Alsip, Illinois.

Financials, Fundamental Metrics & Ratios
Revenue (Most Recent Fiscal Year) $44.88M
Net Income (Most Recent Fiscal Year) $-2.56M
PE Ratio (Current Year Earnings Estimate) --
PE Ratio (Trailing 12 Months) --
PEG Ratio (Long Term Growth Estimate) --
Price to Sales Ratio (Trailing 12 Months) --
Price to Book Ratio (Most Recent Quarterly Book Value per Share) 0.23
Price to Cash Ratio (Most Recent Annual Cash Flow per Share) --
Pre-Tax Margin (Trailing 12 Months) --
Net Margin (Trailing 12 Months) --
Return on Equity (Trailing 12 Months) --
Return on Assets (Trailing 12 Months) --
Current Ratio (Most Recent Fiscal Quarter) 0.97
Quick Ratio (Most Recent Fiscal Quarter) 0.41
Debt to Common Equity (Most Recent Fiscal Quarter) 0.22
Inventory Turnover (Trailing 12 Months) --
Book Value per Share (Most Recent Fiscal Quarter) $-19.40
Earnings per Share (Most Recent Fiscal Quarter) --
Earnings per Share (Most Recent Fiscal Year) --
Diluted Earnings per Share (Trailing 12 Months) --
Stock
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Common Shares Outstanding 7.29M
Free Float 2.98M
Market Capitalization $8.24M
Average Volume (Last 20 Days) 1.68M
Beta (Past 60 Months) -0.81
Percentage Held By Insiders (Latest Annual Proxy Report) 59.14%
Percentage Held By Institutions (Latest 13F Reports) 2.55%
Annual Dividend (Based on Last Quarter) $0.00
Dividend Yield (Based on Last Quarter) 0.00%